Open AccessCost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women WithERBB2(HER2)–Positive Breast Cancer
Author(s) -
Natalia Kunst,
ShiYi Wang,
Annette Hood,
Sarah S. Mougalian,
Michael P. DiGiovanna,
Kerin B. Adelson,
Lajos Pusztai
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.27074
Subject(s) - breast cancer , oncology , medicine , adjuvant , neoadjuvant therapy , gynecology , cancer , obstetrics
This economic evaluation modeled the cost-effectiveness of 5 neoadjuvant-adjuvant treatment strategies for women with ERBB2 -positive breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom